CAS NO: | 153504-70-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | Cevimeline hydrochloride hemihydrate (SNI-2011) is a quinuclidine derivative of acetylcholine and a selective and orally activemuscarinic M1 and M3 receptoragonist. Cevimeline hydrochloride hemihydrate stimulates secretion by the salivary glands and can be used as a sialogogue for xerostomia[1][2][3][4]. Cevimeline hydrochloride hemihydrate can cross the blood-brain barrier (BBB)[5]. | ||||||||||||||||
IC50& Target | Muscarinic M1 and M3 receptor[1] | ||||||||||||||||
体外研究 (In Vitro) | In digested parotid cells, Cevimeline (0.1-100 μM) increases the intracellular Ca2+concentration[1]. | ||||||||||||||||
体内研究 (In Vivo) | Cevimeline (0.008-0.016 mg/kg; intraperitoneal injection; male Wistar rats) treatment shows slowly increasing and lasting salivation, and increased blood flow increment in the parotid gland and pressor response. Cevimeline inhibits angiotensin II-induced water intake and neuronal activity in the subfornical organ at 0.016 mg/kg[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 244.78 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C10H17NOS.HCl.1/2H2O | ||||||||||||||||
CAS 号 | 153504-70-2 | ||||||||||||||||
中文名称 | 盐酸西维美林半水合物 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(408.53 mM;Need ultrasonic) H2O : ≥ 50 mg/mL(204.27 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|